Development of a biocompatible polymeric chitosan system for the release of compounds with leishmanicidal activity
Leishmaniasis is a tropical disease caused by parasites of the genus Leishmania spp; it presents different clinical manifestations, of which cutaneous leishmaniasis is the most common form, and it is endemic in more than 70 countries worldwide. Only four drugs are registered for the treatment of the...
Guardado en:
Autores principales: | Jorge Higuita-Castro, Iván D. Vélez, Diana M. Escobar, Javier Murillo, Tatiana Pineda, Victoria Ospina, Sara M. Robledo |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e3207489cef647789f04466d3db7679c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Comparative efficacy of amphotericin B-loaded chitosan nanoparticles and free amphotericin B drug against Leishmania tropica
por: Aamir Sohail, et al.
Publicado: (2021) -
SYNTHESIS AND IN VITRO LEISHMANICIDAL AND CYTOTOXIC ACTIVITIES OF 2-STYRYLQUINOLINES ANALOGS
por: Ana M. MESA, et al.
Publicado: (2009) -
Chitosan And N, N, N-Trimethyl Chitosan Nanoparticle Encapsulation Of Ocimum Gratissimum Essential Oil: Optimised Synthesis, In Vitro Release And Bioactivity
por: Onyebuchi C, et al.
Publicado: (2019) -
Leishmaniasis Recidivans in Rural Venezuela
por: Ariadna Perez Sanchez, et al.
Publicado: (2020) -
Chiclero's ulcer: An unusual presentation of Leishmania tropica in Syria
por: Alexey Youssef, et al.
Publicado: (2018)